Navigation Links
Dan Renick, RPh, Joins The Hobart Group as Managing Partner
Date:5/28/2008

Strengthens firm's ability to drive clients' success in managed care

GLADSTONE, N.J., May 28 /PRNewswire/ -- The Hobart Group, a full-service managed market agency focused on securing formulary access for today's pharmaceutical brands, announces the addition of Dan Renick, RPh, as Managing Partner. Renick will provide strategic counsel to The Hobart Group's pharmaceutical and biotech clients, including GlaxoSmithKline, sanofi-aventis, and Forest Laboratories.

"Dan brings a unique managed care perspective to The Hobart Group and our clients," said Lisa B. Bair, President. "His knowledge of what matters to payers during the formulary decision process, in particular, Medicare Part D, will help address a critical need for our clients."

"There is more pressure than ever on drugmakers to maximize revenues of their key assets. In today's market, it's critical that companies are able to effectively differentiate their drugs from the competition," said Renick. "I'm excited to apply my knowledge of what payers are looking for with our clients. As the healthcare environment evolves, it is critical to provide our managed market customers with strategies that deliver innovative solutions to obtaining formulary access."

Prior to joining The Hobart Group, Renick served as Director, Corporate Pharmacy Management, at Humana Inc., a national managed care organization with more than 11 million members and the second largest Medicare Part D and Medicare Advantage sponsor. In this role, Renick was responsible for Pharmacy Programs and trade relations, including contracting oversight with both pharmaceutical companies and pharmacy provider organizations. At Merck & Co., Inc., Renick worked with large employers, business coalitions, and benefits consultants in support of rational and evidence-based benefit-design decisions.

In addition, he has worked with various other managed market segments with an emphasis on Senior Care, and spent several years in pharmacy operations at the regional and headquarters level for both retail and long-term care pharmacy providers. Renick earned his RPh degree from the University of Kentucky and his BS degree in chemistry and biology from Western Kentucky University.

About The Hobart Group

The Hobart Group is a full-service managed market agency providing specialized services aimed at obtaining formulary access. The Hobart Group has developed a full suite of technology tools to help enhance relationships with payer customers. For more information about The Hobart Group, visit http://www.thehobartgroup.com.


'/>"/>
SOURCE The Hobart Group
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
2. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
3. Hank Plain Joins Morgenthaler Ventures as Partner
4. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
5. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
6. Dan Broderick Joins Prolog Ventures as Partner
7. Ingenuity Systems Joins Biomarkers Consortium
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
10. Progeniq Joins Microsoft in Bio IT Alliance
11. Jeffrey H. Buchalter Joins MacroGenics Board of Directors as Chairman
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... FL (PRWEB) , ... October ... ... (RPS®) today announces publication of a United States multicenter, prospective clinical study ... use, disposable, point-of-care diagnostic test capable of identifying clinically significant acute bacterial ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
Breaking Biology Technology:
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
Breaking Biology News(10 mins):